Strategies to alleviate heat stress on performance and physiological parameters in feedlot-finished cattle under heat stress conditions. A systematic review-meta-analysis

Strategies to alleviate heat stress on live performance - dry matter intake (DMI), average daily gain (ADG), and feed conversion efficiency (FCE) - and on physiological parameters - respiratory rate (RR) and panting score (PS) - of feedlot-finished cattle were evaluated by systematic review-meta-analysis. Using the PICO framework were identified 3813 records, with 31 publications and 6729 cattle being considered in the meta-analysis (MA). The comparison most reported was sun vs. shade (n = 24 publications), followed by shade vs. shade (area per animal and effectivity in reduce solar load) (n = 7 publications) and sun vs. sprinkling (n = 4 publications). Cattle with access to shade with total reduction in solar load improved ADG (p = 0.008) and FCE (p = 0.024), and reduced RR (p < 0.001) compared to unshaded animals. Cattle with access to shade with a height between 3 and 4 m increased ADG (p < 0.001), tended to improve FCE (p = 0.054), and reduced RR (p < 0.001) compared to unshaded animals. An area of shade from 2 to 4 m2/animal increased ADG (p = 0.002), and higher than 4 m2/animal reduced RR (p < 0.001) compared to unshaded animals. Animals that received sprinkling volume below 1 L/animal/min improved ADG (p = 0.008) compared to unshaded animals. Cattle with access to shade with a high area per animal improved DMI (p = 0.023) and ADG (p < 0.001) compared to animals with a low area. In univariate meta-regression, it was observed that the variables significantly (P < 0.05) influencing DMI were THI category; influencing ADG were cattle gender, THI category, and coat color; influencing FCE were cattle age and hemisphere; and influencing RR were country, THI category and climate. Performance and physiological parameters of feedlot-finished cattle under heat stress depend on animal and environmental characteristics.

Mesenchymal Stromal Cell Secretome for Therapeutic Application in Skin Wound Healing: A Systematic Review of Preclinical Studies

Non-healing skin wounds remain a challenge in the healthcare system. In this sense, it is suggested that the secretome of mesenchymal stromal cells (MSCs) can be effective as a therapeutic strategy for regenerative medicine. Therefore, this systematic review aimed to determine the effects of treatment with a secretome derived from MSCs on the healing of skin wounds in a preclinical model of rodents (mice and rats). Studies were systematically retrieved from 6 databases and gray literature that provided 1,172 records, of which 25 met the inclusion criteria for qualitative analysis. Results revealed substantial heterogeneity among studies concerning experimental designs and methodologies, resulting in a high risk of bias. Together, the selected studies reported that treatment improved wound healing by (1) accelerating wound closure and improving skin repair quality; (2) reducing inflammation by decreasing the number of cells and inflammatory cytokines, accompanied by polarization of the M2 macrophage; (3) complete re-epithelialization and epidermal reorganization; (4) neovascularization promoted by proliferation of endothelial cells (CD34+) and increased levels of pro-angiogenic mediators; (5) better scar quality promoted by increased expression of collagen types I and III, as well as improved deposition and remodeling of collagen fibers. In conclusion, despite the need for alignment of methodological protocols and transparent reports in future studies, results show that the secretome of MSCs from different tissue sources corresponds to a promising tool of regenerative medicine for the treatment of skin wounds.

Administration of mesenchymal stem cells from adipose tissue at the hip joint of dogs with osteoarthritis: A systematic review

This systematic review aimed to determine the effects of intra-articular administration of mesenchymal stem cells from adipose tissue in dogs with hip joint osteoarthritis (OA). Clinical trials were systematically reviewed, using PubMed, EMBASE, Cochrane Library, LILACS, Web of Science, Scopus, Open Grey, Google Scholar, and ProQuest Dissertation and Thesis without publication year restrictions. References were screened and selected based on predefined eligibility criteria by two independent reviewers, according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Clinical outcomes were assessed quantitatively using clinical pain scores, physical examination, imaging examination, questionnaire responses, pain in manipulation, gait analysis, range of joint motion, and adverse effects. The risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Checklist. Out of 1483 articles, six met the inclusion criteria for qualitative analysis, with two randomized controlled trials and four before-and-after studies. All studies reported significantly better clinical outcomes in the adipose tissue stem cells (ADSC) group with improvements in pain and function and decreased evidence of hip OA. The risk of bias was categorized as high in the before-and-after studies and moderate to high in the randomized studies. The studies were considered heterogeneous owing to clinical results and methodology. Because of this heterogeneity, it was not possible to perform meta-analysis. Assessments of ADSC reports yielded positive clinical effects that showed improvements in pain and function and decreased evidence of hip osteoarthritis. More high-level, larger-cohort dog studies that utilize standardized protocols are needed.